Meanwhile, multiple studies in ESCC used the tumor proportion score (TPS), which reflects the percentage of PD-L1 staining relative to all viable tumor cells in the sample, not considering other cells in the TME [26,47,51]. The gene discussed is CD274; the disease is neoplasm.